SEC Goes After Theradoc Exec For Improper Transfers
The U.S. Securities and Exchange Commission has accused Hospira Inc. subsidiary Theradoc Inc.'s controller Paul R. Beckwith of illegally transferring corporate funds out of Theradoc's operating account into accounts for his...To view the full article, register now.
Already a subscriber? Click here to view full article